Subject: l(2)CA61VS
Hi John,
Kathy asked for l(2)CA61VS to be entered into FlyBase.
It is a new gene-allele for us and was apparently provided by you in this
stock:
b1 esg35Ce-1 pr1 cn1 bw1 l(2)CA61VS/SM5
quote from Kathy:
'which was placed in the Mid-America Stock Center by the Ashburner lab
and is now in the Bloomington collection.'
Is there anything you can tell us about this stock:
mutagen
phenotype (I know it is lethal but at what stage etc)
discoverer
etc
thanks,
Ele
>
Subject: Re: l(2)CA61VS
Hi Ele,
CA61 is an unmapped gene whose existence is inferred from the lack of
complementation between VS2, VS8 (both esg alleles) and Df(2L)b80k,
Df(2L)b88c25 (neither of which remove esg), i.e. all four stocks are
mutant for CA61.
Df(2L)b80k and Df(2L)b88c25 complement all other esg alleles.
VS2 and VS8 are from the same screen of Pat Simpson.
b80k and b88c25 are from Alexandrov (but 8 years apart).
John
Subject: l(2)35CcAM7
Kathy wrote:
>I have l(2)35CcAM7 in a stock from Bowling Green, to them from the
>Ashburner lab. Perhaps you could get a pc on this one too from JR32.
How about it then John??!!
We have the gene but know nothing about the mutation.
Ele
>
Subject: Re: l(2)35CcAM7
The stock is rd9.
The existence of 35Cc is inferred from the lethality of rd9. I guess rd9
cannot be both a deletion and a point mutation of 35Cc.
Take your pick!
John